Page last updated: 2024-08-24

glucuronic acid and Experimental Hepatoma

glucuronic acid has been researched along with Experimental Hepatoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liao, YT; Liu, CH; Wu, KC; Yu, J1
Florczyk, SJ; Kievit, FM; Leung, M; Park, JO; Veiseh, O; Wu, J; Zhang, M1
ISHIZAWA, T; ODASHIMA, S1
ISHIDATE, M; ISHIZAWA, T; ODASHIMA, S1
Fan, ZZ; Gao, H; Gu, W; Heng, P; Li, Q; Li, XQ; Liu, XH; Sun, J1
Cahill, PA; Halberstadt, CR; Jablonski, EM; Koniaris, LG; McKillop, IH; Moran, DM1
Huang, FY; Huang, YH; Li, YN; Lin, YY; Tan, GH; Wang, H1
Ma, HL; Maitani, Y; Nagai, T; Qi, XR; Xu, YF1
Eriksson, LC; Farber, E; Rinaudo, JA; Roomi, MW1

Other Studies

9 other study(ies) available for glucuronic acid and Experimental Hepatoma

ArticleYear
Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Alginates; Animals; Delayed-Action Preparations; Diffusion; Doxorubicin; Glucuronic Acid; Hep G2 Cells; Hexuronic Acids; Humans; Liver Neoplasms, Experimental; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Porosity; Silicon Dioxide; Treatment Outcome

2014
Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance.
    Pharmaceutical research, 2010, Volume: 27, Issue:9

    Topics: Alginates; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Resistance, Neoplasm; Glucuronic Acid; Hexuronic Acids; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Tissue Scaffolds; Xenograft Model Antitumor Assays

2010
On the correlation between chemical carcinogenes and their metabolism. II. The effect of sodium glucuronate or glucuronolactone on the development of liver cancer in rats fed D.A.B.
    Gan, 1957, Volume: 48, Issue:4

    Topics: Animals; Bile Ducts, Intrahepatic; Carcinogens; Glucuronates; Glucuronic Acid; Liver Neoplasms; Liver Neoplasms, Experimental; Rats; Sodium

1957
On the correlation between chemical carcinogenes and their metabolism. II. The effect of sodium glucuronate or glucuronolactone on the development of liver cancer in rats fed D.A.B.
    Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15(Suppl 1)

    Topics: Animals; Bile Ducts, Intrahepatic; Carcinogens; Glucuronates; Glucuronic Acid; Liver Neoplasms; Liver Neoplasms, Experimental; Rats; Sodium

1959
[Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2006, Volume: 4, Issue:4

    Topics: Alginates; Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Proliferation; Glucuronic Acid; Hexuronic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Microspheres; Random Allocation; Rats

2006
Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression.
    Cell transplantation, 2006, Volume: 15, Issue:8-9

    Topics: Alginates; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Disease Progression; Drug Compounding; Drug Implants; Enzyme-Linked Immunosorbent Assay; Glucuronic Acid; Hexuronic Acids; Interleukin-6; Liver Neoplasms, Experimental; Male; Rats; Transfection

2006
Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin.
    World journal of gastroenterology, 2007, May-07, Volume: 13, Issue:17

    Topics: Alginates; Animals; Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Endoglin; Glucuronic Acid; Hexuronic Acids; Immunization, Passive; Intracellular Signaling Peptides and Proteins; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Microspheres; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Survival Rate

2007
Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    International journal of pharmaceutics, 2008, Apr-16, Volume: 354, Issue:1-2

    Topics: Alginates; Animals; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Glucuronic Acid; Half-Life; Hexuronic Acids; Injections, Intravenous; Kupffer Cells; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Nanoparticles; Rabbits; Rats; Rats, Sprague-Dawley; Spleen; Tissue Distribution; Xenograft Model Antitumor Assays

2008
Kinetics of excretion of 2-acetylaminofluorene in normal and xenobiotic-treated rats and in rats with hepatocyte nodules.
    Laboratory investigation; a journal of technical methods and pathology, 1989, Volume: 60, Issue:3

    Topics: 2-Acetylaminofluorene; Animals; Bile; Esters; Glucuronates; Glucuronic Acid; Liver; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344; Rats, Inbred Strains; Tissue Distribution

1989